Frontiers in Aging Neuroscience | Alzheimer's Disease and Related Dementias

Original Research

Published on 15 Jun 2023

Development and validation of an interpretable machine learning model—Predicting mild cognitive impairment in a high-risk stroke population

in Alzheimer's Disease and Related Dementias

Feng-Juan Yan
Xie-Hui Chen
Xiao-Qing Quan
Li-Li Wang
Xin-Yi Wei
Jia-Liang Zhu

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1180351

3,396 views
5 citations

Perspective

Published on 08 Jun 2023

Latin American women in dementia research: outstanding contributions, barriers, and opportunities from Argentinian, Chilean, and Colombian colleagues

in Alzheimer's Disease and Related Dementias

Sol Fittipaldi
Sandra Baez
Carolina Gonzalez-Silva
Claudia Duran-Aniotz

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1168414

2,207 views
1 citation

Original Research

Published on 07 Jun 2023

A cross-sectional study of explainable machine learning in Alzheimer’s disease: diagnostic classification using MR radiomic features

in Alzheimer's Disease and Related Dementias

Stephanos Leandrou
Demetris Lamnisos
Haralabos Bougias
Nikolaos Stogiannos
Eleni Georgiadou
K. G. Achilleos
Constantinos S. Pattichis
Alzheimer’s Disease Neuroimaging Initiative

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1149871

3,811 views
8 citations

Original Research

Published on 07 Jun 2023

Gut microbiota and intestinal barrier function in subjects with cognitive impairments: a cross-sectional study

in Alzheimer's Disease and Related Dementias

Ying Pei
Yan Lu
HuiZi Li
ChengYing Jiang
Lei Wang

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1174599

4,964 views
13 citations

Original Research

Published on 05 Jun 2023

Decoding the genetic relationship between Alzheimer’s disease and type 2 diabetes: potential risk variants and future direction for North Africa

in Alzheimer's Disease and Related Dementias

Wided Boukhalfa
Haifa Jmel
Nadia Kheriji
Ismail Gouiza
Hamza Dallali
Mariem Hechmi
Rym Kefi

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1114810

3,799 views
2 citations

Original Research

Published on 05 Jun 2023

c-Abl tyrosine kinase down-regulation as target for memory improvement in Alzheimer’s disease

in Alzheimer's Disease and Related Dementias

Rilda León
Daniela A. Gutiérrez
Claudio Pinto
Cristian Morales
Catalina de la Fuente
Cristóbal Riquelme
Bastián I. Cortés
Adrián González-Martin
David Chamorro
Nelson Espinosa

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1180987

3,770 views
5 citations

Original Research

Published on 02 Jun 2023

The efficacy of memory load on speech-based detection of Alzheimer’s disease

in Alzheimer's Disease and Related Dementias

Minju Bae
Myo-Gyeong Seo
Hyunwoong Ko
Hyunsun Ham
Keun You Kim
Jun-Young Lee

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1186786

2,700 views
1 citation

Mini Review

Published on 02 Jun 2023

Neuronal ApoE4 in Alzheimer’s disease and potential therapeutic targets

in Alzheimer's Disease and Related Dementias

Lan Zhang
Yiyuan Xia
Yuran Gui

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1199434

12,896 views
17 citations

Original Research

Published on 02 Jun 2023

Uncovering neuroinflammation-related modules and potential repurposing drugs for Alzheimer's disease through multi-omics data integrative analysis

in Alzheimer's Disease and Related Dementias

Shensuo Li
Changhao Lu
Zhenzhen Zhao
Dong Lu
Guangyong Zheng

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1161405

3,798 views
7 citations

Original Research

Published on 02 Jun 2023

The correlation between changes in gray matter microstructure and cerebral blood flow in Alzheimer’s disease

in Alzheimer's Disease and Related Dementias

Xiaoxi Niu
Ying Guo
Zhongyu Chang
Tongtong Li
Yuanyuan Chen
Xianchang Zhang
Hongyan Ni

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1205838

2,740 views
3 citations

Systematic Review

Published on 31 May 2023

Network meta-analysis of comparative efficacy of animal-assisted therapy vs. pet-robot therapy in the management of dementia

in Alzheimer's Disease and Related Dementias

Hongdi Du
Lin Bo
Xiaoxing Lai
Hongwei Zhu
Xiaopeng Huo

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1095996

4,892 views

Editorial

Published on 31 May 2023

Editorial: Current advances in genetic presentations of dementia and aging, volume II

in Alzheimer's Disease and Related Dementias

Yuzhen Xu
Ulises Gomez-Pinedo
Jun Liu
Daojun Hong
Jun Xu

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1202532

2,173 views

Original Research

Published on 30 May 2023

Eliciting brain waves of people with cognitive impairment during meditation exercises using portable electroencephalography in a smart-home environment: a pilot study

in Alzheimer's Disease and Related Dementias

Ioulietta Lazarou
Vangelis P. Oikonomou
Lampros Mpaltadoros
Margarita Grammatikopoulou
Vasilis Alepopoulos
Thanos G. Stavropoulos
Anastasios Bezerianos
Spiros Nikolopoulos
Ioannis Kompatsiaris
Magda Tsolaki

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1167410

6,093 views
4 citations

Original Research

Published on 30 May 2023

Apolipoprotein E ε4 accelerates the longitudinal cerebral atrophy in open access series of imaging studies-3 elders without dementia at enrollment

in Alzheimer's Disease and Related Dementias

Yuda Huang
Yongzhi Shan
Wen Qin
Guoguang Zhao

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1158579

2,668 views
1 citation

Systematic Review

Published on 30 May 2023

An update on mobile applications collecting data among subjects with or at risk of Alzheimer's disease

in Alzheimer's Disease and Related Dementias

Lydia Piendel
Martin Vališ
Jakub Hort

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1134096

3,477 views
2 citations

Study Protocol

Published on 26 May 2023

The ANeED study – ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial

in Alzheimer's Disease and Related Dementias

Luiza Jadwiga Chwiszczuk
Monica Haraldseid Breitve
Bjørn-Eivind Bordewick Kirsebom
Per Selnes
John Chr. Fløvig
Anne-Brita Knapskog
Ragnhild E. Skogseth
Jessica Hubbers
Elin Holst-Larsen
Arvid Rongve

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1163184

6,906 views
4 citations

Navigation group

Articles

Development and validation of an interpretable machine learning model—Predicting mild cognitive impairment in a high-risk stroke population

Latin American women in dementia research: outstanding contributions, barriers, and opportunities from Argentinian, Chilean, and Colombian colleagues

A cross-sectional study of explainable machine learning in Alzheimer’s disease: diagnostic classification using MR radiomic features

Gut microbiota and intestinal barrier function in subjects with cognitive impairments: a cross-sectional study

Decoding the genetic relationship between Alzheimer’s disease and type 2 diabetes: potential risk variants and future direction for North Africa

c-Abl tyrosine kinase down-regulation as target for memory improvement in Alzheimer’s disease

The efficacy of memory load on speech-based detection of Alzheimer’s disease

Neuronal ApoE4 in Alzheimer’s disease and potential therapeutic targets

Uncovering neuroinflammation-related modules and potential repurposing drugs for Alzheimer's disease through multi-omics data integrative analysis

The correlation between changes in gray matter microstructure and cerebral blood flow in Alzheimer’s disease

Network meta-analysis of comparative efficacy of animal-assisted therapy vs. pet-robot therapy in the management of dementia

Editorial: Current advances in genetic presentations of dementia and aging, volume II

Eliciting brain waves of people with cognitive impairment during meditation exercises using portable electroencephalography in a smart-home environment: a pilot study

Apolipoprotein E ε4 accelerates the longitudinal cerebral atrophy in open access series of imaging studies-3 elders without dementia at enrollment

An update on mobile applications collecting data among subjects with or at risk of Alzheimer's disease

The ANeED study – ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial